
Oppilotech
Developing the next generation of antibiotics with novel mechanisms of action.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | Grant | ||
Total Funding | 000k |
Related Content
Oppilotech operates in the biotechnology sector, focusing on drug discovery and development. The company serves pharmaceutical and biotech firms by providing a high-resolution computational platform that leverages systems biology and machine learning to model biological processes within cells. This platform aids in the identification of viable drug targets, which is crucial for the development of breakthrough medicines. Oppilotech's business model revolves around collaborative partnerships and licensing agreements, generating revenue through service fees and royalties from successful drug discoveries. The company is dedicated to selecting the right drug targets to ensure the success of developing and delivering impactful treatments for various diseases.
Keywords: Biotechnology, Drug Discovery, Computational Modelling, Systems Biology, Machine Learning, Pharmaceutical, Biotech, Drug Targets, Predictive Modelling, Collaborative Partnerships.